NCT02377388View on ClinicalTrials.gov

DPP-4 Inhibitors and Acute Myocardial Infarction:Effects on Platelet Function

PHASE3CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

February 7, 2017

Primary Completion Date

February 28, 2020

Study Completion Date

February 28, 2020

Conditions
Platelet Aggregation During Acute Myocardial Infarction
Interventions
DRUG

sitagliptin OR saxagliptin

sitagliptin OR saxagliptin tablets, 48(+-24) hours after the beginning of an AMI,and both arms in use of dual anti-platelet therapy (DAPT) .

DRUG

placebo

placebo tablets, 48(+-24) hours after the beginning of an AMI,and both arms in use of dual anti-platelet therapy (DAPT) .

Trial Locations (1)

01406000

Heart Institute(InCor)-Acute Coronary Care Unit, São Paulo

All Listed Sponsors
collaborator

InCor Heart Institute

OTHER

lead

University of Sao Paulo General Hospital

OTHER

NCT02377388 - DPP-4 Inhibitors and Acute Myocardial Infarction:Effects on Platelet Function | Biotech Hunter | Biotech Hunter